Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Anti-MAGE-A3-DP4 TCR T-cells|
|Synonyms||Anti-MAGE-A3-DP4 TCR PBL|
Anti-MAGE-A3-DP4 TCR T-cells are patient-derived T-lymphocytes that are modified to express a T-cell receptor that recognizes human melanoma antigen 3 (MAGEA3), which may result in increased killing of MAGE-A3-expressing tumor cells (PMID: 27163739).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Aldesleukin + Anti-MAGE-A3-DP4 TCR T-cells + Cyclophosphamide + Fludarabine||Aldesleukin Anti-MAGE-A3-DP4 TCR T-cells Cyclophosphamide Fludarabine||0||1|
|Anti-MAGE-A3-DP4 TCR T-cells||Anti-MAGE-A3-DP4 TCR T-cells||0||0|